NEUROONE MEDICAL TECHNOLOGIES Corp - Common Stock, par value, $0.001 per share (NMTC)
CUSIP: 64130M209
Q2 2024 13F Holders as of 30 Jun 2024
- Type / Class
- Equity / Common Stock, par value, $0.001 per share
- Shares outstanding
- 50,013,453
- Total 13F shares
- 2,735,360
- Share change
- -111,460
- Total reported value
- $2,187,702
- Price per share
- $0.80
- Number of holders
- 18
- Value change
- -$97,024
- Number of buys
- 11
- Number of sells
- 5
Quarterly Holders Quick Answers
What is CUSIP 64130M209?
CUSIP 64130M209 identifies NMTC - NEUROONE MEDICAL TECHNOLOGIES Corp - Common Stock, par value, $0.001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 64130M209:
Top shareholders of NMTC - NEUROONE MEDICAL TECHNOLOGIES Corp - Common Stock, par value, $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| AWM Investment Company, Inc. |
13F
|
Company |
—
class O/S missing
|
1,450,000
|
$1,740,000 | — | 31 Mar 2024 | |
| Nantahala Capital Management, LLC |
13F
|
Company |
2.4%
|
1,198,912
|
$1,438,694 | — | 31 Mar 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
1.8%
|
919,321
|
$1,103,185 | — | 31 Mar 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.44%
|
221,949
|
$266,419 | — | 31 Mar 2024 | |
| Mayo Clinic |
13F
|
Company |
0.36%
|
181,754
|
$218,105 | — | 31 Mar 2024 | |
| PERKINS CAPITAL MANAGEMENT INC |
13F
|
Company |
0.3%
|
150,000
|
$180,000 | — | 31 Mar 2024 | |
| STATE STREET CORP |
13F
|
Company |
0.1%
|
51,599
|
$61,919 | — | 31 Mar 2024 | |
| MAI Capital Management |
13F
|
Company |
0.1%
|
50,000
|
$60,000 | — | 31 Mar 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.06%
|
30,281
|
$36,337 | — | 31 Mar 2024 | |
| Princeton Global Asset Management LLC |
13F
|
Company |
0.03%
|
16,833
|
$20,200 | — | 31 Mar 2024 | |
| TWO SIGMA SECURITIES, LLC |
13F
|
Company |
0.02%
|
11,310
|
$13,572 | — | 31 Mar 2024 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.01%
|
7,002
|
$8,402 | — | 31 Mar 2024 | |
| Centerpoint Advisors, LLC |
13F
|
Company |
0.01%
|
5,000
|
$6,000 | — | 31 Mar 2024 | |
| SIMPLEX TRADING, LLC |
13F
|
Company |
0%
|
1,720
|
$2,000 | — | 31 Mar 2024 | |
| Nemes Rush Group LLC |
13F
|
Company |
0%
|
433
|
$520 | — | 31 Mar 2024 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0%
|
350
|
$420 | — | 31 Mar 2024 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
193
|
$232 | — | 31 Mar 2024 | |
| UBS Group AG |
13F
|
Company |
0%
|
108
|
$130 | — | 31 Mar 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
55
|
$66 | — | 31 Mar 2024 |
Institutional Holders of NEUROONE MEDICAL TECHNOLOGIES Corp - Common Stock, par value, $0.001 per share (NMTC) as of Q2 2024
As of 30 Jun 2024,
NEUROONE MEDICAL TECHNOLOGIES Corp - Common Stock, par value, $0.001 per share (NMTC) was held by
18 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,735,360 shares.
The largest 10 holders included
Nantahala Capital Management, LLC, VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, Mayo Clinic, PERKINS CAPITAL MANAGEMENT INC, STATE STREET CORP, UBS Group AG, MAI Capital Management, NORTHERN TRUST CORP, and Virtu Financial LLC.
This page lists
18
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
18
Q2 2024 holders
18
Holder diff
0
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 Value $ | Q2 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.